CELYNTRA THERAPEUTICS
0737.829.015 · rovalta.com · 25/09/2026
ACTIVE
CELYNTRA THERAPEUTICS
Financial year 2025 · Closed on 31/12/2025
Net result-3,1 M €+52,1 %over 1 year
Gross margin561 k €+114,6 %over 1 year
Equity-9,6 M €-40,1 %over 1 year
Workforce12,7 ETP0,0 %over 1 year
Overview
Identity
Source · BCE/KBOCELYNTRA THERAPEUTICS is a Public limited company incorporated in 2019. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Mont-Saint-Guibert. It employs on average 12,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0737.829.015
- Incorporation
- 19/11/2019
- Legal form
- Public limited company
- Registered office
- Rue Edouard Belin 2
1435 Mont-Saint-Guibert · WallonieSee on map - Contributed capital
- 352 300,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 12,7 ETP
Joint committees (1)
- 20700
Signals
Healthy social debts
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 561 k € | +115% | -3,8 M € | -360% | -837,4 k € | -744% | -99,2 k € | +61.5% | -257,8 k € |
| EBITDA | -876,6 k € | +82.5% | -5 M € | -498% | -837,8 k € | -744% | -99,2 k € | +61.6% | -258,2 k € |
| Operating result | -3 M € | +52.1% | -6,3 M € | -634% | -861,2 k € | -602% | -122,6 k € | +56.4% | -281,6 k € |
| Net result | -3,1 M € | +52.1% | -6,4 M € | -572% | -951,2 k € | -673% | -123,1 k € | +62.6% | -328,9 k € |
| Balance sheet | |||||||||
| Equity | -9,6 M € | -40.1% | -6,9 M € | -1044% | -598,9 k € | +65.7% | -1,7 M € | -7.6% | -1,6 M € |
| Total assets | 8,2 M € | +3.4% | 7,9 M € | +189% | 2,7 M € | +2516% | 105 k € | -39.7% | 174,1 k € |
| Cash | 445 k € | +207% | 144,8 k € | -93.1% | 2,1 M € | +3541% | 57,6 k € | -43.6% | 102,2 k € |
| Debts | 17,6 M € | +19.4% | 14,8 M € | +447% | 2,7 M € | +46.2% | 1,9 M € | +3.0% | 1,8 M € |
| Other | |||||||||
| Workforce | 12,7 ETP | 0.0% | 12,7 ETP | – | – | – | |||
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Jason Conner
ActiveEnded mandates
Gustavo Mahler
EndedStefan Braam
EndedStefan Braam
EndedOther companies at this address
Rue Edouard Belin 2 1435 Mont-Saint-Guibert| Company | CBE no. |
|---|---|
Cellistic● Active | 0740.785.238 |
Ncardia Holding● Active | 0565.979.162 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/06/2026 | 16/10/2025 | 24/07/2024 | 30/06/2023 | 23/09/2022 | 30/09/2021 |
| General meeting | 05/06/2026 | 30/09/2025 | 07/06/2024 | 20/06/2023 | 09/09/2022 | 23/09/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 05/06/2026 | 10/06/2026 | French | |
| Abridged model | 31/12/2024 | 30/09/2025 | 16/10/2025 | French | |
| Abridged model | 31/12/2023 | 07/06/2024 | 24/07/2024 | French | |
| Abridged model | 31/12/2022 | 20/06/2023 | 30/06/2023 | French | |
| Abridged model | 31/12/2021 | 09/09/2022 | 23/09/2022 | French | |
| Abridged model | 31/12/2020 | 23/09/2021 | 30/09/2021 | French | |
| Abridged model | 31/12/2019 | 24/07/2020 | 30/07/2020 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Jason Conner
ActiveEnded mandates
Gustavo Mahler
EndedStefan Braam
EndedStefan Braam
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates12/06/2026DEMISSIONS, NOMINATIONS
- Mandates07/05/2026DEMISSIONS, NOMINATIONS
- Mandates26/08/2024DEMISSIONS, NOMINATIONS
- Capital / shares20/09/2023CAPITAL, ACTIONS
- Registered office31/03/2023SIEGE SOCIAL
- Mandates21/06/2022DEMISSIONS, NOMINATIONS
- Other21/11/2019RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-3,1 M €↑
- 2024Annual accounts 2024-6,4 M €↓
- 2023Annual accounts 2023-951,2 k €↓
- 2022Annual accounts 2022-123,1 k €↑
- 2021Annual accounts 2021-328,9 k €↑
- 2020Annual accounts 2020-520,6 k €↑
- 2019Annual accounts 2019-836,6 k €
- 19/11/2019IncorporationPublic limited company